Seattle Genetics, Inc.
(NASDAQ:SGEN)|
7.67 -0.99 (-11.43%) Dec 01 - Close |
|
|
|
After-Hours 9.86 +2.19 (28.55%) Mon, 1 Dec 2008 6:50 PM
- Compare SGEN with:
- View: Line | Candlestick
Company Profile
Seattle Genetics, Inc.
21823 30th Drive SE
Bothell, WA 98021
United States - Map
Phone: (425) 527-4000
Fax: (425) 527-4001
Website: www.seattlegenetics.com
State of incorporation: Delaware
CEO: Dr. Clay B. Siegall, Ph.D.
Employees: 189
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Is a biotechnology company
A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.
Recent news for SGEN
-
Seattle Genetics to Present at Upcoming Investor Conferences
Business Wire - 11 hours ago
-
SEATTLE GENETICS INC /WA Financials
EDGAR Online Financials - Nov 14 at 9:04 ET
-
SEATTLE GENETICS INC /WA Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 07 at 4:17 ET
-
World's Scariest Stock: Dendreon
Motley Fool - Oct 31 at 10:01 ET
-
Seattle Genetics to Present at the Oppenheimer Healthcare Conference
Business Wire - Oct 29 at 8:00 ET
-
Seattle Genetics Presents on SGN-70 at American College of Rheumatology Meeting
Business Wire - Oct 28 at 11:00 ET
-
Health Winners & Losers: Omrix
TheStreet.com - Oct 27 at 3:01 ET
-
Seattle Genetics upgraded by Oppenheimer
Briefing.com - Oct 27 at 5:58 ET
-
New Star Analyst Rankings for SEATTLE GENETICS I
StarMine - Oct 25 at 8:20 ET
-
Seattle Genetics, Inc. Q3 2008 Earnings Call Transcript
Seeking Alpha - Oct 24 at 8:24 ET